• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部用米诺地尔与局部用阿法骨化醇治疗女性雄激素性脱发的疗效与安全性比较。

Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.

作者信息

Blume-Peytavi Ulrike, Kunte Christian, Krisp Andreas, Garcia Bartels Natalie, Ellwanger Ulf, Hoffmann Rolf

机构信息

Department of Dermatology and Allergy, Charité- Medical University, Berlin, Germany.

出版信息

J Dtsch Dermatol Ges. 2007 May;5(5):391-5. doi: 10.1111/j.1610-0387.2007.06295.x.

DOI:10.1111/j.1610-0387.2007.06295.x
PMID:17451383
Abstract

BACKGROUND

Two drugs which are approved for the treatment of androgenetic alopecia in women in Germany were compared with regard to their influence on hair growth.

PATIENTS AND METHODS

Patients were randomized to group I (n = 52) who used 2% minoxidil solution twice daily for a period of 12 months or to group II (n = 51) who used 0.025% alfatradiol solution once daily for 6 months and were then switched to 2% minoxidil solution for months 7-12. Changes in hair growth parameters were determined using the TrichoScan.

RESULTS

Topical treatment with 2% minoxidil solution for 6 months resulted in a significant increase of cumulative hair thickness (p < 0.0001) and absolute hair density (p < or = 0.0025), whereas these parameters of hair growth remained nearly unchanged after 6 months of treatment with alfatradiol solution. Evaluation of the same parameters from month 7 to month 12 demonstrated that 12 months minoxidil treatment resulted in an increasing stabilization (group I). After the alfatradiol-->minoxidil switch in group II a significant increase in cumulative hair thickness (p < 0.0001) and absolute hair density (p < 0.0001) was achieved. Both study medications were well tolerated.

CONCLUSIONS

Treatment with minoxidil can induce an increase in hair density and hair thickness,whereas treatment with alfatradiol results in deceleration or stabilization of hair loss.

摘要

背景

比较了德国两种已获批用于治疗女性雄激素性脱发的药物对头发生长的影响。

患者与方法

将患者随机分为两组,第一组(n = 52)每天使用两次2%米诺地尔溶液,持续12个月;第二组(n = 51)每天使用一次0.025%阿法骨化醇溶液,持续6个月,然后在第7至12个月改用2%米诺地尔溶液。使用毛发扫描仪(TrichoScan)测定头发生长参数的变化。

结果

外用2%米诺地尔溶液治疗6个月后,累积毛发厚度显著增加(p < 0.0001),绝对毛发密度增加(p ≤ 0.0025),而使用阿法骨化醇溶液治疗6个月后,这些头发生长参数几乎没有变化。对第7至12个月相同参数的评估表明,米诺地尔治疗12个月后效果逐渐稳定(第一组)。在第二组中,从阿法骨化醇改用米诺地尔后,累积毛发厚度(p < 0.0001)和绝对毛发密度(p < 0.0001)显著增加。两种研究药物耐受性良好。

结论

米诺地尔治疗可增加毛发密度和厚度,而阿法骨化醇治疗可减缓或稳定脱发。

相似文献

1
Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.局部用米诺地尔与局部用阿法骨化醇治疗女性雄激素性脱发的疗效与安全性比较。
J Dtsch Dermatol Ges. 2007 May;5(5):391-5. doi: 10.1111/j.1610-0387.2007.06295.x.
2
A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.一项关于5%和2%外用米诺地尔溶液治疗女性型脱发的随机、安慰剂对照试验。
J Am Acad Dermatol. 2004 Apr;50(4):541-53. doi: 10.1016/j.jaad.2003.06.014.
3
Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.局部用氟维司群溶液对男性和绝经后女性雄激素性脱发无效:两项随机概念验证研究的结果
Br J Dermatol. 2008 Jan;158(1):109-15. doi: 10.1111/j.1365-2133.2007.08276.x. Epub 2007 Nov 6.
4
Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.女性雄激素性脱发。外用2%米诺地尔溶液治疗。
Arch Dermatol. 1994 Mar;130(3):303-7.
5
A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.一项关于1%外用米诺地尔溶液治疗日本女性雄激素性脱发的随机、安慰剂对照试验。
Eur J Dermatol. 2007 Jan-Feb;17(1):37-44. doi: 10.1684/ejd.2007.0187. Epub 2007 Feb 27.
6
A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.一项针对女性雄激素性脱发的 5%米诺地尔泡沫每日一次与 2%米诺地尔溶液每日两次治疗的随机、单盲试验。
J Am Acad Dermatol. 2011 Dec;65(6):1126-1134.e2. doi: 10.1016/j.jaad.2010.09.724. Epub 2011 Jun 23.
7
Topical minoxidil therapy for androgenetic alopecia. A 30-month study.外用米诺地尔治疗雄激素性脱发。一项为期30个月的研究。
Arch Dermatol. 1987 Nov;123(11):1483-7.
8
A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.一项多中心、随机、安慰剂对照、双盲临床试验,比较5%米诺地尔新型外用泡沫制剂与安慰剂治疗男性雄激素性脱发的疗效。
J Am Acad Dermatol. 2007 Nov;57(5):767-74. doi: 10.1016/j.jaad.2007.04.012. Epub 2007 Aug 29.
9
An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.口服非那雄胺与5%外用米诺地尔治疗男性雄激素性脱发的开放性、随机对照研究
Dermatology. 2004;209(2):117-25. doi: 10.1159/000079595.
10
Is topical minoxidil solution effective on androgenetic alopecia in routine daily practice?在日常临床实践中,外用米诺地尔溶液对雄激素性脱发是否有效?
J Dermatolog Treat. 2007;18(5):268-70. doi: 10.1080/09546630701383727.

引用本文的文献

1
Female-pattern hair loss: therapeutic update.女性型脱发:治疗进展。
An Bras Dermatol. 2023 Jul-Aug;98(4):506-519. doi: 10.1016/j.abd.2022.09.006. Epub 2023 Mar 30.
2
Design and Validation of a Sensitive Multisteroid LC-MS/MS Assay for the Routine Clinical Use: One-Step Sample Preparation with Phospholipid Removal and Comparison to Immunoassays.设计和验证一种用于常规临床应用的高灵敏度多甾体 LC-MS/MS 分析方法:一步法样品制备并去除磷脂与免疫分析的比较。
Int J Mol Sci. 2022 Nov 24;23(23):14691. doi: 10.3390/ijms232314691.
3
Development of a curated Hershberger database.
赫什伯格数据库的构建。
Reprod Toxicol. 2018 Oct;81:259-271. doi: 10.1016/j.reprotox.2018.08.016. Epub 2018 Sep 8.
4
Review of quality of life studies in women with alopecia.女性脱发患者生活质量研究综述。
Int J Womens Dermatol. 2018 Jan 9;4(1):18-22. doi: 10.1016/j.ijwd.2017.11.007. eCollection 2018 Mar.
5
Conventional and novel stem cell based therapies for androgenic alopecia.用于雄激素性脱发的传统和新型干细胞疗法。
Stem Cells Cloning. 2017 Aug 31;10:11-19. doi: 10.2147/SCCAA.S138150. eCollection 2017.
6
Interventions for female pattern hair loss.女性型脱发的干预措施。
Cochrane Database Syst Rev. 2016 May 26;2016(5):CD007628. doi: 10.1002/14651858.CD007628.pub4.
7
Female pattern hair loss.女性型脱发
Int J Endocrinol Metab. 2013 Oct 21;11(4):e9860. doi: 10.5812/ijem.9860. eCollection 2013 Oct.
8
Female pattern alopecia: current perspectives.女性型脱发:当前观点
Int J Womens Health. 2013 Aug 29;5:541-56. doi: 10.2147/IJWH.S49337.
9
The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study.17α-雌二醇(Ell-Cranell® alpha 0.025%)溶液治疗女性型脱发的疗效和安全性:单中心、开放标签、非对照、IV期研究。
Ann Dermatol. 2012 Aug;24(3):295-305. doi: 10.5021/ad.2012.24.3.295. Epub 2012 Jul 25.
10
[Hormones and hair growth].[激素与头发生长]
Hautarzt. 2010 Jun;61(6):487-95. doi: 10.1007/s00105-009-1890-2.